4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-002469
Chief Development Officer sold 2,840 shares at $30.05 ($85,342)
- Chief Development Officer acquired 9,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…